Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-07 Sale |
2025-02-11 7:40 pm |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
13,015 | $153.89 | $2,002,878 | 70,948 (Indirect Direct) |
View |
| 2024-12-12 Purchase |
2024-12-12 5:27 pm |
JOHNSON & JOHNSON | JNJ | WEINBERGER MARK A Director |
1,000 | $147.22 | $147,220 | 1,000 (Direct) |
View |
| 2024-08-30 Sale |
2024-09-03 4:48 pm |
JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller |
5,635 | $165.06 | $930,113 | 19,721 (Indirect Direct) |
View |
| 2024-03-13 Sale |
2024-03-13 4:36 pm |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs |
8,891 | $162.16 | $1,441,765 | 15,043 (Direct) |
View |
| 2024-02-16 Sale |
2024-03-06 3:42 pm |
CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
3,725 | $25.81 | $96,142 | 4,103,430 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-07 Exercise |
2025-02-11 7:41 pm |
2018-02-10 2025-02-09 |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine |
58,504 | $100.06 | 165,919 (Direct) |
View |
| 2025-02-07 Tax Withholding |
2025-02-11 7:41 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine |
47,436 | $153.12 | 165,919 (Direct) |
View |
| 2025-02-07 Exercise |
2025-02-11 7:40 pm |
2018-02-10 2025-02-09 |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
13,015 | $100.06 | 70,948 (Direct) |
View |
| 2024-12-10 Option Award |
2024-12-12 5:16 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director |
209 | $149.67 | 2,805 (Direct) |
View |
| 2024-12-10 Option Award |
2024-12-12 5:09 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
335 | $149.67 | 11,380 (Direct) |
View |
| 2024-05-01 Tax Withholding(A) |
2024-10-31 5:57 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D |
10,984 | $144.59 | 65,087 (Direct) |
View |
| 2024-05-01 Exercise(A) |
2024-10-31 5:57 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D |
25,255 | $0 | 65,087 (Direct) |
View |
| 2024-05-22 Gift |
2024-10-21 6:18 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
137,725 | $0 | 70,930 (Direct) |
View |
| 2024-04-25 Option Award |
2024-10-15 4:39 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | DAVIS D SCOTT Director |
1,386 | $0 | 15,604 (Direct) |
View |
Ownership |
2024-10-09 5:07 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer |
0 | $0 | 95,211 (Direct) |
View |
| 2024-09-10 Option Award |
2024-09-12 4:44 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director |
188 | $165.94 | 2,574 (Direct) |
View |
| 2024-09-10 Option Award |
2024-09-12 4:43 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
303 | $165.94 | 10,955 (Direct) |
View |
| 2024-08-30 Exercise |
2024-09-03 4:48 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller |
5,635 | $100.06 | 19,721 (Direct) |
View |
| 2024-08-30 Exercise |
2024-09-03 4:48 pm |
2018-02-10 2025-02-09 |
JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller |
5,635 | $0 | 19,721 (Direct) |
View |
| 2024-07-08 Tax Withholding |
2024-07-09 5:48 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs |
5,018 | $147.16 | 19,834 (Direct) |
View |
| 2024-07-08 Exercise |
2024-07-09 5:48 pm |
2024-07-01 N/A |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs |
9,809 | $0 | 19,834 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 5:07 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director |
211 | $147.85 | 2,368 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 5:07 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
315 | $147.85 | 10,573 (Direct) |
View |
| 2024-05-01 Tax Withholding |
2024-05-03 4:31 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D |
10,984 | $144.59 | 65,087 (Direct) |
View |
| 2024-05-01 Exercise |
2024-05-03 4:31 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D |
22,255 | $0 | 65,087 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 5:06 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Beckerle Mary C Director |
1,386 | $0 | 13,643 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 5:06 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
1,386 | $0 | 10,173 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 5:06 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | West Nadja Director |
1,386 | $0 | 5,094 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 5:06 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Adamczyk Darius Director |
1,386 | $0 | 3,713 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 5:06 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director |
1,386 | $0 | 2,139 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 5:06 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | MULCAHY ANNE M Director |
1,386 | $0 | 21,471 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 5:06 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | WEINBERGER MARK A Director |
1,386 | $0 | 9,129 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 5:06 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | McClellan Mark B. Director |
1,386 | $0 | 17,868 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 5:05 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Joly Hubert Director |
1,386 | $0 | 6,464 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 5:05 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Johnson Paula A Director |
1,386 | $0 | 2,859 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 5:05 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Doudna Jennifer A Director |
1,386 | $0 | 8,082 (Direct) |
View |
Ownership |
2024-04-10 5:05 pm |
N/A N/A |
Contineum Therapeutics Inc. | CTNM | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
0 | $0 | 1,979,173 (Indirect) |
View |
| 2024-03-05 Option Award |
2024-03-07 4:58 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director |
753 | $159.8 | 1,245 (Direct) |
View |
| 2024-03-05 Option Award |
2024-03-07 4:58 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
235 | $159.8 | 8,788 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-06 3:42 pm |
N/A N/A |
CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
79 | $5.141 | 4,103,430 (Indirect) |
View |
| 2024-02-29 Exercise |
2024-03-06 3:42 pm |
N/A N/A |
CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
584 | $1.186 | 4,103,430 (Indirect) |
View |
| 2024-02-29 Exercise |
2024-03-06 3:42 pm |
N/A N/A |
CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
2,940 | $0.237 | 4,103,430 (Indirect) |
View |
| 2024-02-29 Exercise |
2024-03-06 3:42 pm |
N/A N/A |
CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
252 | $3.955 | 4,103,430 (Indirect) |
View |
| 2024-02-16 Exercise |
2024-03-06 3:42 pm |
N/A N/A |
CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
607,225 | $0 | 4,103,430 (Indirect) |
View |
| 2024-02-29 Exercise |
2024-03-06 3:42 pm |
N/A 2024-11-18 |
CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
3,855 | $0 | 4,103,430 (Indirect) |
View |
| 2024-02-16 Exercise |
2024-03-06 3:42 pm |
N/A N/A |
CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
607,725 | $0.158 | 4,103,430 (Indirect) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:58 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine |
81,763 | $0 | 81,763 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:56 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
31,094 | $0 | 31,094 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:56 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech |
52,743 | $0 | 52,743 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:55 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | Hait William EVP, Chief EI and Med Officer |
36,851 | $0 | 36,851 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:55 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO |
25,220 | $0 | 25,220 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:55 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D |
69,211 | $0 | 69,211 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:55 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
101,110 | $0 | 101,110 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:55 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel |
49,289 | $0 | 49,289 (Direct) |
View |